UiPath Inc. (PATH) PT Lowered to $40 at Needham & Company

UiPath Inc. (PATH) PT Lowered to $40 at Mizuho Securities

Mizuho Securities analyst Siti Panigrahi lowered the price target on UiPath Inc. (NYSE: PATH) to $40.00 (from $70.00) while maintaining a Buy rating.... More

UiPath Inc. (PATH) PT Lowered to $32 at RBC Capital

RBC Capital analyst Matthew Hedberg lowered the price target on UiPath Inc. (NYSE: PATH) to $32.00 (from $37.00) while maintaining a Sector Perform rating.... More

UiPath Inc. (PATH) PT Lowered to $29 at BMO Capital

BMO Capital analyst Keith Bachman lowered the price target on UiPath Inc. (NYSE: PATH) to $29.00 (from $52.00) while maintaining a Market Perform rating.... More

UiPath Inc. (PATH) PT Lowered to $35 at Wells Fargo

Wells Fargo analyst Michael Turrin lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $45.00) while maintaining a Overweight rating.... More

UiPath (PATH) Stock Tumbles 15% on Dramatic Growth Slowdown, Guidance Embeds 'Significant Conservatism' Says Analyst

Shares of UiPath (NYSE: PATH) are down nearly 15% in premarket trading Thursday after the company released a weaker-than-expected Q1 revenue forecast.

The software maker reported Q4 adjusted EPS of 5c, well above the analyst consensus of 2.6c per share. Total revenue in the quarter came in at $289.7 million.

For the first quarter, UiPath expects revenue in the range of $223 million to $225 million, missing the consensus estimates of $246.4 million. The company expects Q1 adjusted operating loss in... More

UiPath Inc. (PATH) PT Lowered to $35 at BofA Securities

BofA Securities analyst Brad Sills lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $50.00) while maintaining a Buy rating.... More

UiPath Inc. (PATH) PT Lowered to $30 at Canaccord Genuity

Canaccord Genuity analyst David Hynes Jr. lowered the price target on UiPath Inc. (NYSE: PATH) to $30.00 (from $55.00) while maintaining a Hold rating.... More

UiPath Inc. (PATH) PT Drops 23% to $57.50 at Credit Suisse After Guiding Well Below Consensus

Credit Suisse analyst Phil Winslow lowered the price target on UiPath Inc. (NYSE: PATH) to $57.50 (from $75.00) after reporting FQ4 ARR growth accelerating to 59.4% y/y from 57.9% y/y in FQ3. Operating margin increased as well, to 14.5% (vs. consensus 6.6%) from 4.1% y/y in FQ3. However, guidance... More

UiPath Inc. (PATH) PT Lowered to $23 at Wolfe Research

Wolfe Research lowered its price target on UiPath Inc. (NYSE: PATH) to $23.00 (from $36.00) while maintaining a Peerperform rating.... More

UiPath Inc. (PATH) PT Lowered to $38 at Macquarie

Macquarie analyst Frederick Havemeyer lowered the price target on UiPath Inc. (NYSE: PATH) to $38.00 (from $47.00) while maintaining a Outperform rating.... More

UiPath Inc. (PATH) PT Lowered to $35 at Oppenheimer

Oppenheimer analyst Brian Schwartz lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $56.00) while maintaining a Outperform rating.... More

UiPath Inc. (PATH) PT Lowered to $41 at Morgan Stanley

Morgan Stanley analyst Keith Weiss lowered the price target on UiPath Inc. (NYSE: PATH) to $41.00 (from $74.00) while maintaining a Overweight rating.... More

After-Hours Stock Movers 03/30: (OEG) (PRG) (CORT) Higher; (PATH) (EXFY) (MASI) Lower (more...)

After-Hours Stock Movers:

UiPath Inc. (NYSE: PATH) 20% LOWER; reported fourth-quarter EPS of $0.05, versus the consensus of $0.03. Revenue for the quarter came in at $289 million versus the consensus estimate of $283.03 million. Looking for Q1 2023 revenue of $223-225 million, below the consensus of $243.1 million.

Expensify, Inc. (NASDAQ: EXFY)... More

UiPath Inc. (PATH) Tops Q4 EPS by 2c, Guidance Misses Estimates

(Updated - March 30, 2022 4:09 PM EDT)

UiPath Inc. (NYSE: PATH) reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $289 million versus the consensus estimate of $283.03 million.

GUIDANCE:

UiPath Inc. sees Q1 2023... More